Rapid Nutrition PLC Embarks on an Exciting Journey into Chinese Consumer Market
China’s Strong Demand for Natural Products Spells Opportunity for International Brands
London, United kingdom 11 July 2023 – Rapid Nutrition PLC (Euronext Growth: ALRPD), a globally renowned natural wellness company, is thrilled to provide further details on its entry strategy into Asia, commencing with the Chinese consumer market. With a laser focus on capitalising on this immense opportunity, Rapid Nutrition aims to unlock and bridge the gap between the massive consumer demand that exists in one of the world's largest economies.
Projected growth trajectory over the first three years:
- Year 1: Anticipated sales revenue between USD $1 million and USD $1.7 million, with operational expenses estimated at approximately USD $0.685 million.
- Year 2: Projected sales revenue between USD $4 million and USD $5.2 million, with operational expenses estimated at approximately USD $0.720 million.
- Year 3: Projected sales revenue between USD $8 million and USD $10.2 million, with operational expenses estimated at approximately USD $1.44 million.
China, home to over 1.4 billion people, represents an enormous market with a growing middle class and increasing disposable income. The rise of e-commerce and the country's rapidly expanding internet penetration have paved the way for unprecedented growth and accessibility for businesses looking to tap into this market.
Simon St Ledger, CEO of Rapid Nutrition PLC, expressed managements optimism about the company's entry into the Chinese market, stating, "China is experiencing double-digit growth across the health and wellness sector. Furthermore, cross-border e-commerce serves as the conduit for international brands such as Rapid Nutrition, as China's 'Blue Hat' registration system for health foods and nutritional supplements is essentially reserved for Chinese companies. In many ways, the natural products industry is 'built for e-commerce.' Only about 16-17% of transactions in the West occur online. In China, that number pre-COVID was 51% in consumer-product verticals. For the dietary supplement industry, like many others, the figure today may be north of 80%."
Entering the Chinese market requires a meticulous approach, and Rapid Nutrition PLC is fully committed to leveraging its capital-efficient business model, combined with strong partnerships, to successfully navigate this exciting venture.
With a deep understanding of the immense potential offered by the Asia Pacific market, Rapid Nutrition PLC aims to unlock new horizons by offering its core brands, by making available its flagship SystemLS weight loss range to Chinese consumers. By delivering innovative and high-quality nutritional products, Rapid Nutrition PLC seeks to establish itself as a trusted brand that resonates with the evolving demands of Chinese consumers, further boosting investor confidence.
The Company aims to disclose a comprehensive presentation showcasing Rapid Nutrition's entrance into the Chinese consumer market in the forthcoming weeks, providing shareholders with additional valuable insights and details.
About Rapid Nutrition
Dedicated to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are “made by nature, refined by science.” Rapid Nutrition’s first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice globally by offering premium brands with the highest-quality ingredients to deliver maximum results.
For more information, please visit http://rnplc.com
Investor Relations Contact:
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," “projects,” “opportunity,” and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).